These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 33224690)

  • 1. Management of treatment-resistant generalized anxiety disorder.
    Ansara ED
    Ment Health Clin; 2020 Nov; 10(6):326-334. PubMed ID: 33224690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of generalized anxiety disorder with pregabalin, an atypical anxiolytic.
    Strawn JR; Geracioti TD
    Neuropsychiatr Dis Treat; 2007 Apr; 3(2):237-43. PubMed ID: 19300556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Antidepressant Treatment of Generalized Anxiety Disorder.
    Zahreddine N; Richa S
    Curr Clin Pharmacol; 2015; 10(2):86-96. PubMed ID: 23438725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New approaches to the pharmacological management of generalized anxiety disorder.
    Buoli M; Caldiroli A; Caletti E; Paoli RA; Altamura AC
    Expert Opin Pharmacother; 2013 Feb; 14(2):175-84. PubMed ID: 23282069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders.
    Tassone DM; Boyce E; Guyer J; Nuzum D
    Clin Ther; 2007 Jan; 29(1):26-48. PubMed ID: 17379045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of treatments for refractory generalized anxiety disorder: a systematic review.
    Samuel M; Zimovetz EA; Gabriel Z; Beard SM
    Int Clin Psychopharmacol; 2011 Mar; 26(2):63-8. PubMed ID: 21088608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregabalin for the treatment of generalized anxiety disorder.
    Wensel TM; Powe KW; Cates ME
    Ann Pharmacother; 2012 Mar; 46(3):424-9. PubMed ID: 22395254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP
    Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating antidepressant treatment prior to adding second-line therapies among patients with treatment-resistant depression.
    Hassan AK; Farmer KC; Brahm NC; Neas BR
    Int J Clin Pharm; 2016 Apr; 38(2):429-37. PubMed ID: 26935957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Etiological factors of generalized anxiety disorder].
    Gosselin P; Laberge B
    Encephale; 2003; 29(4 Pt 1):351-61. PubMed ID: 14615705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention.
    Bandelow B; Wedekind D; Leon T
    Expert Rev Neurother; 2007 Jul; 7(7):769-81. PubMed ID: 17610384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Place of Antipsychotics in the Therapy of Anxiety Disorders and Obsessive-Compulsive Disorders.
    Pignon B; Tezenas du Montcel C; Carton L; Pelissolo A
    Curr Psychiatry Rep; 2017 Nov; 19(12):103. PubMed ID: 29110139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation with atypical antipsychotics for depression: a review of evidence-based support from the medical literature.
    Wright BM; Eiland EH; Lorenz R
    Pharmacotherapy; 2013 Mar; 33(3):344-59. PubMed ID: 23456734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A literature review of quetiapine for generalized anxiety disorder.
    Kreys TJ; Phan SV
    Pharmacotherapy; 2015 Feb; 35(2):175-88. PubMed ID: 25689246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review.
    Gao K; Muzina D; Gajwani P; Calabrese JR
    J Clin Psychiatry; 2006 Sep; 67(9):1327-40. PubMed ID: 17017818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregabalin augmentation of antidepressants in older patients with comorbid depression and generalized anxiety disorder-an open-label study.
    Karaiskos D; Pappa D; Tzavellas E; Siarkos K; Katirtzoglou E; Papadimitriou GN; Politis A
    Int J Geriatr Psychiatry; 2013 Jan; 28(1):100-5. PubMed ID: 22431439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current theoretical models of generalized anxiety disorder (GAD): conceptual review and treatment implications.
    Behar E; DiMarco ID; Hekler EB; Mohlman J; Staples AM
    J Anxiety Disord; 2009 Dec; 23(8):1011-23. PubMed ID: 19700258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.